# Core Molding Technologies

Type: Company (CMT)

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/core-molding-technologies
Canonical HTML page: https://getbiobrief.com/entity/core-molding-technologies

## Timeline

- **2025-11-01**: Pipeline Update — Initial Phase 1 data released for LB2102 in solid tumors at a major medical conference.
- **2025-06-15**: Manufacturing Expansion — Obelisc facility in Belgium reaches full operational status for clinical and commercial supply.
- **2025-03-10**: FY 2025 Earnings — Legend Biotech reports full-year results and commercial highlights.

## Recent coverage (1 stories)

### Legend Biotech Reports Robust 2025 Growth Driven by Carvykti Scaling
2026-03-10 13:50:46 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Legend Biotech (LEGN) has announced its fourth-quarter and full-year 2025 financial results, showcasing a significant surge in net trade sales for its CAR-T therapy, Carvykti. The company continues to expand its manufacturing footprint and advance its pipeline in solid tumors, solidifying its position as a leader in the cell therapy market.
Full story: https://getbiobrief.com/story/legend-biotech-q4-2025-results-carvykti-growth

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.